ZAS Corporation Ltd. proudly participated in the prestigious AGM & International Chest Congress 2026, a renowned scientific gathering that brought together leading pulmonologists, respiratory medicine specialists, academicians, and healthcare professionals from Bangladesh and abroad.
During the congress, ZAS Corporation Ltd. showcased its specialized respiratory and critical care therapeutic portfolio, reflecting the company’s continued commitment to advancing healthcare solutions for respiratory and chest-related diseases. The event provided an excellent platform to share scientific knowledge, exchange clinical insights, and discuss the latest developments in pulmonary healthcare and patient management.
Throughout the program, representatives from ZAS Corporation Ltd. actively engaged with healthcare professionals and industry experts, fostering meaningful discussions on innovative treatment approaches and emerging trends in respiratory medicine. These interactions reinforced the company’s dedication to supporting the medical community with high-quality, patient-centric healthcare solutions.
Participation in the AGM & International Chest Congress 2026 further demonstrates ZAS Corporation Ltd.’s ongoing commitment to contributing to medical excellence, continuous scientific advancement, and improved patient outcomes in respiratory care.
ZAS Corporation Ltd. remains steadfast in its mission to collaborate with healthcare professionals and organizations in shaping a healthier future through innovation, quality, and excellence.
